Skip to main content
Clinical Trials/NCT03337958
NCT03337958
Unknown
Not Applicable

Evaluation of an Educational Intervention in the Management of Inhalers With Tablet and Ventilatory Reeducation: a Randomized Clinical Study

Universidad de Granada1 site in 1 country15 target enrollmentStarted: December 1, 2017Last updated:

Overview

Phase
Not Applicable
Enrollment
15
Locations
1
Primary Endpoint
Respiratory parameters

Overview

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of an educational intervention in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

Detailed Description

The importance of this pathology lies not only in its high prevalence, which is expected to increase due to the aging of society but also in its high mortality. In Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. The clinical development of COPD includes periods of stability interspersed with symptomatic exacerbations, which usually involve hospitalization. During these hospitalizations, respiratory symptoms are worsening.Nevertheless, in Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. Thus, it is very important the pharmacological education in this patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Inclusion criteria were to be clinically diagnosed of exacerbation of COPD, to possess pharmacological treatment in the form of inhalers.

Exclusion Criteria

  • Exclusion criteria were inability to provide informed consent, presence of psychiatric or cognitive disorders, neurological disorders, organ failure, cancer or inability to cooperate. Patients who had experienced an exacerbation of prior COPD in less than one month were excluded.

Outcomes

Primary Outcomes

Respiratory parameters

Time Frame: baseline, 12 months

Changes from baseline to postintervention in respiratory parameters using a spirometer. The most important respiratory parameters evaluated is forced expiratory volume in the first second (FEV1)

Secondary Outcomes

  • Dyspnea level(baseline, 12 months)
  • Knowledge of the disease(Baseline, 12 months)
  • Cognitive Level(Baseline)
  • Functional independence(Baseline)
  • Anxiety-depression level(Baseline)
  • Adhesion to inhalers(Baseline)
  • Physical fitness(baseline, 12 months)
  • Technique of the inhaler(baseline, 12 months)
  • Respiratory parameters(baseline, 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marie Carmen Valenza

Principal investigator

Universidad de Granada

Study Sites (1)

Loading locations...

Similar Trials